Half Year 2022 Clinuvel Pharmaceuticals Ltd Earnings Call Transcript
Good evening. I'm Verity Wai-Smith from Monsoon Communications. Thank you for joining us for CLINUVEL'S half-year report investor presentation. I'll now hand over to Malcolm Bull to begin.
Thank you, Verity. And greetings to all who have taken time to join us today. It's my pleasure to discuss the financial results for the half year to December 31, 2021, and more generally, the growth and expansion of the CLINUVEL group. And I'm discussing that with Darren Keamy and Lachlan Hay.
Before progressing further, participants should please note that we will be talking about our plans and making forward-looking statements. So I'll briefly highlight our legal notice, which outlines that there are many risks that can impact the achievement of plans. And a copy of these notices is on our website and accompanies every company announcement. So many of you will be familiar with it.
Also, unless otherwise stated, any references we make today to dollars refer
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
